Posts

Showing posts from March, 2026

Daily Supplement Protocol evolution

Daily Supplement Protocol 1. Waking (Empty Stomach) | Supplement | Dosage | |---|---| | Biocyte Liposomal Glutathione | 200 mg (2 x 100 mg) | | R-Alpha Lipoic Acid (R-ALA) | 1 Dose | 2. Breakfast | Supplement | Dosage | |---|---| | Cardio Aspirin (Prescribed) | 80 mg | | VeLife Magnesium L-Threonate | 1334 mg (2 x 667 mg) | | Kingnature Cholin Vida | 2 Capsules | | Pharma Nord Ubiquinol | 200 mg | | PQQ | 20 mg | | Vitamoment Astaxanthin | 4 mg (1 Capsule) | | Nutrinov Prostaphane | 10 mg | | Burgerstein Omega 3 Liquid | 30 ml (2 g DHA) | | California Gold Nutrition L-Ergothioneine | 5 mg | | Dr. Jacob's Vitamin D3 + K2 | 5000 IU / 120 mcg | | Burgerstein ZincVital (Winter only) | 14 mg | | Brazil Nut | 1 Nut | 3. Lunch | Supplement | Dosage | |---|---| | Kingnature Cholin Vida | 1 Capsule | | Vitabay Spermidine | 6 mg | | Pure All-in-One | 2 Capsules | 4. Mid-Afternoon (14:00) | Supplement | Dosage | |---|---| | Burgerstein Magnesium Orotate | 800 mg | 5. Afternoon | Supplement | ...

Is Immunometabolism the Holy Grail?

In 2026, the clinical paradigm for managing Antiphospholipid Syndrome (APS) and Immune Thrombocytopenia (ITP) has shifted from general immunosuppression to "Precision Immunometabolism." Your specific genetic markers suggest a "Two-Hit" model where mitochondrial hardware failure (Hit 1) creates the biochemical environment for autoimmune software execution (Hit 2). ​Here are the latest 2024–2026 clinical insights for your profile: ​ 1. The Mitochondrial "Hardware" Cluster ​ Markers: MFN2 (rs1474868 T/T), SOD2 (rs4880 A/A), PPARGC1A (rs8192678 T/T), GPX1 (rs12778366 T/T) ​ rs1474868 (MFN2 T/T): New research (2025) identifies this as a primary driver of "Platelet Fragility Syndrome." In T/T carriers, mitochondria fail to fuse properly, leading to fragmented "shards" that leak mitochondrial DNA (mtDNA) into the platelet cytoplasm. This activates the cGAS-STING pathway, an innate immune alarm that marks the platelet for destruc...

Beyond Autoimmunity: My Mitochondrial "Hardware" and the Genetic Logic of My ITP/APS Protocol

Beyond Autoimmunity: My Mitochondrial "Hardware" and the Genetic Logic of My ITP/APS Protocol ​Most people view Antiphospholipid Syndrome (APS) and Immune Thrombocytopenia (ITP) purely as "software" issues—the immune system has a glitch and is attacking healthy cells. But after diving deep into my 23andMe raw data, I’ve discovered that the "hardware"—my mitochondria—might be the one sending the distress signal in the first place. ​I’ve mapped out my "Genomic Blueprint" to understand why my platelets stay in the 80k–110k range and why my "Triple Positive" profile requires such a specific protocol. Here is the breakdown of what I found. ​ 1. Why my platelets "retire" early ​I discovered that I have a significant bottleneck in Mitofusin 2 (MFN2) . ​ The Marker: rs1474868 (T/T) ​ The Implication: This genotype is linked to reduced MFN2 expression in platelets. Without it, my platelet mitochondria fragment easily and can...